Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
23 Cards in this Set
- Front
- Back
Binding Affinity (or affinity)
|
The degree of a chemical attraction between a ligand and a receptor
(can be high or low) |
|
Efficacy (or intrinsic activity)
|
The ability of a bound ligand to ACTIVATE the receptor
(whether a drug is going to bind or not) |
|
Dose-response curve (DRC).
Wide vs Narrow therapeutic ED & LD |
A graph of the relationship between drug doses and the effects.
-Wide therapeutic: More safe to take higher dose -Narrow therapeutic: Small increase in dose can kill you ED: EFFECTIVE DOSE LD: LETHAL DOSE |
|
Metabolic Tolerance
|
Organ systems become more effective at eliminating the drug
|
|
Functional Tolerance
|
Target tissue may show altered sensitivity to the drug by changing the number of receptors:
-Neurons DOWN REGULATE in response to agonist drug, making fewer recepetors available -They UP-REGULATE in response to an antagonist |
|
Cross-tolerance
|
tolerance to a drug becomes generalized to other drugs in its class
|
|
How can a Drug alter the Presynaptic Neuron??
|
Through:
-Transmitter Production -Transmitter release (autoreceptors- more or less NT) -Transmitter clearance (block re-uptake) & causes more NT out in synaptic gap |
|
How can a Drug alter the Postsynaptic Neuron??
|
-Transmitter receptors (Block or Open)
-Effects on cellular processes (alters number of postmen. receptors & modulation of second messengers) |
|
Psychoactive Drugs: that can relieve symptoms of Antischzophrenics:
|
(reduce synaptic activity by blocking receptors)
-Antipsychotic (neuroleptic) drugs: Selective antagonists of dopamine D2 receptors -Atypical neuroleptics: Block serotonin receptors |
|
Psychoactive Drugs:
Antidepressant drugs: used to treat mood (affective) disorders |
(INCREASES synaptic transmission)
-MONOAMINE OXIDASE(MAO)-inhibitors prevents the breakdown of monoamines at the synapses -Accumulation of transmitters and prolonging their activity is a major feature of antidepressants. -TRICYCLIC ANTIDEPRESSANTS: block reuptake of serotonin and norepinephrine (accumulates in synapse)(improves depression) -SELECTIVE SEROTONIN REUPTAKE INHIBITORS(SSRIs): like Prozac or Celexa act specifically Blocks reuptake of transmitter at at serotonergic synapses. |
|
Psychoactive Drugs:
Anxiolytics |
-DEPRESSANTS: drugs that reduce nervous system activity (reduces excitability of neurons) (ex: alcohol & opium)
-BARBITURATES: early anxiolytic drug and sleep aid that acts as a depressant- Additive and easily overdosed -BENZODIAZEPINE- acts as agonists on GABA(A) receptors and enhance inhibitory effects of GABA |
|
Psychoactive Drugs:
Opiates |
main ingredient: MORPHINE, an effective analegesic(or pain killer)
-Morphine and Heroin: both highly addictive -Opiates(like morphine, heroin, & codeine) bind to OPIOD RECEPTORS in the brain, especially in the pariaqueductal gray. -Endogenous Opioids-enkephalins, endorphins, & dynorphins: are peptides produced in brain, also additive |
|
Psychoactive Drugs: Alters consciousness
Nicotine |
from tobacco, acts as stimulant
-increases heart rate, blood pressure, digestive action, and alertness. -Acts as an agonist on NICOTINIC ACh RECEPTORS on the ventral tegmental area(VTA) |
|
Psychoactive Drugs:
Alcohol |
-Effects are biphasic: Att first it acts as stimulant, but prolonged acts as depressant(inhibition of neural activity).
-Acts via agonist of GABA receptors -Abuse damages nerve cells in many brain regions FETAL ALCOHOL SYNDROME: Mother drinks while prego, causes damage to fetus; results in deformity, & stunted brain growth Adults: Abuse affects frontal lobes, effects are reversible with abstinence Bingeing may cause brain damage & reduce rate of neurogenesis |
|
Effects of chronic alcohol on brain:
|
-Alcohol-related dementia
-Wernicke-Korsakoff syndrome (not direct effect) confusion, disorientation, coordination, & movement problems. -Retrograde & anterograde amnesia. -confabulations -Cardiovascular problems -Liver damage: Fatty liver, alcoholic hepatitis, cirrhosis |
|
Psychoactive Drugs:
Marijuana |
main ingredient; delta-9-tetrahydrocannabinol (THC)
-Effects vary: include relaxation, mood alteration, stimulation, hallucination, & paranoia -Brain contains specific cannabinoid receptors to mediate the effects of THC -ENDOCANNABINOIDS-analogs of marijuana produced in the brain, such as ANANDAMIDE(which can produce hunger, poor memory, & reduced sensitivity to pain) Beneficial? -Studies on effects: relieving pain & lowering blood pressure CANNABINOID RECEPTORS:-presynaptic membranes. Found in Hippocampus, Basal ganglia, Cerebellum, Frontal Cortex |
|
Stimulants: What?
& Two examples |
-Increases nervous system activity, By increasing excitatory synaptic potentials (alert, activating affect) OR decreasing inhibitory activity.
1.CAFFEINE- blocks presynaptic adenosine receptors, resulting in increased transmitter release and then increases brain activity. 2.COCAINE- blocks monoamine transmitter reuptake (dopamine), which causes monoamines to accumulate in synapses |
|
Synthetic stimulants:
|
Made in Lab. Amphetamine or methamphetamine:
Superficially resembles cocaine: accumulation of the synaptic monoamine transmitters norepinephrine & dopamine. 2STEP ACTION: 1st: Work in axon terminals, causing larger-than-normal release of transmitter 2nd: Amphetamine then interferes with breakdown of the transmitter and the synapses become potent in their effects on behavior -Prolonged ude leads to symptoms that resemble those of schizophrenia or brain damage |
|
Psychoactive Drugs:
Hallucinogens |
Alters sensory perception and produces unusual experiences, (either in absence of stimulation or distorts existing perceptions).
LSD(acid)- strongly activates serotonin receptors in the visual cortex -mescaline & psilocybin are similar and all produce strong visual effects MDMA(Ecstasy)- hallucinogenic amphetamine derivative. -stimulates visual cortical serotonin receptors |
|
Psychoactive Drugs:
Dissociative Drugs |
Different from hallucinogens:
Produces feelings of depersonalization and detachment from reality. -PCP and Ketamine: Both are antagonists at NMDA-type glutamate receptors |
|
Substance-related Disorders:
(2) |
DEPENDENCE: (addiction) the desire to self administer a drug of abuse (physical need)
SUBSTANCE ABUSE: a pattern of use that does not fully meet the criteria for dependence. (not dependent on the drug, but take it anyway) |
|
Models of Drug Abuse
(4) |
1. The MORAL MODEL- blames the abuser for lack of moral character of lack of self-control
2.DISEASE MODEL- says the abuser requires medical treatment; however, an abnormal condition in abusers has not been identified 3.PHYSICAL DEPENDENCE MODEL-says abusers use drugs to avoid withdrawal symptoms like dysphoria (strong negative feelings that can only be relieved by the drug 4.POSITIVE REWARD MODEL- says drug use is a behavior controlled by positive rewards, with no disease |
|
Medications to treat drug abuse
|
Agonists: partially activate the same pathways
Antagonists: block effects of the abused drug that may produce withdrawal Reward-blocking medications: block positive reward effects Anti-craving medications: reduce appetite Immunization: prompts immune system to remove targeted drugs from circulation before reaching brain |